ABCG5 and neoplasm: Since vitamin K3 functions as an anti-tumor agent and cisplatin—an anticancer drug—resistant cells were also resistant to vitamin K3 treatment [19], ABCG5/ABCG8 may play a role in resistance of cancer cells to vitamin K3 cytotoxicity.